Legal & General Group Plc Makes New Investment in Cabot Corporation $CBT

Legal & General Group Plc purchased a new stake in shares of Cabot Corporation (NYSE:CBTFree Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 75,970 shares of the specialty chemicals company’s stock, valued at approximately $6,900,000.

Other institutional investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Cabot during the second quarter worth about $633,302,000. Norges Bank purchased a new position in Cabot during the 4th quarter worth approximately $49,662,000. Bank of New York Mellon Corp purchased a new position in Cabot during the 2nd quarter worth approximately $57,445,000. AQR Capital Management LLC lifted its stake in Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after acquiring an additional 478,702 shares during the period. Finally, UBS Group AG boosted its holdings in shares of Cabot by 186.7% in the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after acquiring an additional 386,514 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CBT shares. JPMorgan Chase & Co. increased their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Truist Financial set a $100.00 price objective on Cabot in a research note on Wednesday, August 5th. Finally, UBS Group decreased their price objective on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $89.00.

View Our Latest Research Report on CBT

Insider Buying and Selling at Cabot

In other Cabot news, CEO Sean D. Keohane sold 134,895 shares of the company’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the transaction, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 229,597 shares of company stock valued at $19,646,746 in the last three months. Corporate insiders own 3.08% of the company’s stock.

Cabot Price Performance

Shares of NYSE CBT opened at $82.90 on Thursday. The stock has a market capitalization of $4.28 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 10.59 and a beta of 0.83. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The firm’s 50 day simple moving average is $87.15 and its 200-day simple moving average is $81.37. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same period in the previous year, the firm earned $1.90 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts expect that Cabot Corporation will post 6.35 EPS for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. Cabot’s payout ratio is presently 53.24%.

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.